Antagonist Protocol in IVF

• Status: Unknown status
• Trial end date: 2016-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

The antagonist protocol in a novel method of stimulation in the in vitro fertilization (IVF) patients. It has been tried in poor responders, polycystic ovary (PCO) patients and normal females undergoing IVF. Can it be used with the same efficacy in all patients?

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Woman's Health University Hospital, Egypt
• Collaborator: Cairo University
• Treatments: Cetrorelix; Hormone Antagonists; Hormones; Menotropins

Criteria

Inclusion Criteria:

• age: 20- 44 years

• Poor responder females according to Bologna criteria

• Polycystic ovarian disease females according to Rotterdam criteria

• Females with infertility causes other than poor responders, or PCO; male factor or tubal block

Exclusion Criteria:

• refusal to get enrolled in the study

• cases of infertility due to severe male factor